Skip to main content

Structure-Activity Studies on the Corticotropin Releasing Factor Antagonist Astressin, Minimal Sequence Necessary for Antagonistic Activity: Implications for a New Pharmacophoric Model

  • Chapter
Peptides: The Wave of the Future

Part of the book series: American Peptide Symposia ((APSY,volume 7))

  • 14 Accesses

Abstract

Corticotropin Releasing Factor (CRF) is an important physiological regulator of the body response to stressful stimuli [1]. Over-expression of CRF is involved in endocrine, neurologic and psychiatric diseases such as feeding disorders, major depression and anxiety-related disorders. To obtain more insight into the physiological role of CRF, potent peptide antagonists have recently been developed mainly based on the amino acid sequence of CRF, which ultimately led to the discovery of astressin, one of the most potent peptide-based CRF antagonists reported until now [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vale, W., Spiess, J., Rivier, C., Rivier, J. Science 213, 1394–1397 (1981).

    Article  CAS  Google Scholar 

  2. Gulyas, J., Rivier, C., Perrin, M., Koerber, S.C., Sutton, S., Corrigan, A., Lahrichi, S.L., Craig, A.G., Vale, W., Rivier, J. Proc. Natl. Acad. Sci. USA 92, 10575–1079 (1995).

    Article  CAS  Google Scholar 

  3. Gilligan, P.J., Robertson, D.W., Zaczek, R. J. Med. Chem. 43, 1641–1660 (2000).

    Article  CAS  PubMed  Google Scholar 

  4. Keller, P.A., Bowman, M., Dang, K.H., Garner, J., Leach, S.P., Smith, R., McGluskey, A. J. Med. Chem. 42, 2352–2357 (1999).

    Article  Google Scholar 

  5. Rijkers, D.T.S., den Hartog, J.A.J., Liskamp, R.M.J. WO 0129086.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Rijkers, D.T.S., den Hartog, J.A.J., Liskamp, R.M.J. (2001). Structure-Activity Studies on the Corticotropin Releasing Factor Antagonist Astressin, Minimal Sequence Necessary for Antagonistic Activity: Implications for a New Pharmacophoric Model. In: Lebl, M., Houghten, R.A. (eds) Peptides: The Wave of the Future. American Peptide Symposia, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0464-0_339

Download citation

  • DOI: https://doi.org/10.1007/978-94-010-0464-0_339

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-3905-5

  • Online ISBN: 978-94-010-0464-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics